Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial (Q33401684)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial |
scientific article |
Statements
1 reference
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial (English)
1 reference
Michelle Fanale
1 reference
Sattva S Neelapu
1 reference
Nathan Fowler
1 reference
Larry Kwak
1 reference
Fredrick Hagemeister
1 reference
Peter McLaughlin
1 reference
Jorge Romaguera
1 reference
Felipe Samaniego
1 reference
Anas Younes
1 reference
Kimberly Hartig
1 reference
Maria Badillo
1 reference
Ken H Young
1 reference
Richard Champlin
1 reference
Nicolaus Wagner-Bartak
1 reference
Michael Wang
1 reference
Liang Zhang
1 reference
Kate J Newberry
1 reference
Luhong Sun
1 reference
Lei Feng
1 reference
Maria Bejarano
1 reference
Wendy Chen
1 reference
Yiming Chen
1 reference
Catriona Byrne
1 reference
Neda Bell
1 reference
Jerome Zeldis
1 reference
6 June 2012
1 reference
1 reference
13
1 reference
716-723
1 reference
Identifiers
1 reference
1 reference